(Q42226922)

19 October 2017

title

Central neurotoxicity following intracarotid BCNU chemotherapy for malignant gliomas (English)

1 reference

19 October 2017

1 reference

1 reference

1 reference

M S Mahaley

1

1 reference

19 October 2017

R A Whaley

series ordinal

2

1 reference

19 October 2017

M Blue

series ordinal

3

1 reference

19 October 2017

L Bertsch

series ordinal

4

1 reference

19 October 2017

publication date

1 January 1986

1 reference

Journal of Neuro-Oncology

19 October 2017

published in

1 reference

19 October 2017

volume

3

1 reference

19 October 2017

issue

4

1 reference

19 October 2017

page(s)

297-314

1 reference

Hemorrhagic encephalitis produced by selective non-occlusive intracarotid BCNU injection in dogs

19 October 2017

cites work

1 reference

12 December 2020

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery

1 reference

12 December 2020

Intracarotid chemotherapy with a combination of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), cis-diaminedichloroplatinum (cisplatin), and 4'-O-demethyl-1-O-(4,6-O-2-thenylidene-beta-D-glucopyranosyl) epipodophyllotoxin (VM-26) in the treatment of pr

1 reference

12 December 2020

Intra-arterial BCNU chemotherapy for treatment of malignant gliomas of the central nervous system

1 reference

12 December 2020

Report of vascilitis and blindness after intracarotid injection of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) in dogs

1 reference

12 December 2020

Limitations of high dose intra-arterial 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) chemotherapy for malignant gliomas.

1 reference

12 December 2020

BCNU solubility and toxicity in the treatment of malignant astrocytomas

1 reference

12 December 2020

New Implantable Continuous Administration and Bolus Dose Intracarotid Drug Delivery System for the Treatment of Malignant Gliomas

1 reference

12 December 2020

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

1 reference

12 December 2020

Chemotherapy of brain cancer: experimental and clinical studies in localized hypothermic cerebral perfusion.

1 reference

12 December 2020

Ophthalmic and central nervous system complications following intracarotid BCNU (Carmustine).

1 reference

12 December 2020

Isolated perfusion in treatment of advanced carcinoma. Brain and face tumors.

1 reference

12 December 2020

A phase I study of intracarotid artery infusion of cis-Diamminedichloroplatinum(II) in patients with recurrent malignant intracerebral tumors.

1 reference

12 December 2020

A critical evaluation of the principles governing the advantages of intra-arterial infusions

1 reference

12 December 2020

Prediction of BCNU pulmonary toxicity in patients with malignant gliomas: an assessment of risk factors.

1 reference

12 December 2020

Intraarterial 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and systemic chemotherapy for malignant gliomas: a follow-up study

1 reference

12 December 2020

Superselective injection of BCNU through a latex calibrated-leak balloon.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00165578

1 reference

Dimensions Publication ID

19 October 2017

1039130243

0 references

1 reference